Submit Deal

QUINCE THERAPEUTICS

Summary

Quince Therapeutics is a biotechnology company that focuses on acquiring, developing, and commercializing therapeutics.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 492 M

Avg. Deal Size£ 246 M

Market Context

Senior Management

Dirk Thye
CEO
Brendan Hannah
Chief Business Officer and Principal Financial Officer
Guenter R. Janhofer
Chief Medical Officer

Sort

brendan hannah

Chief Business Officer and Principal Financial Officer at QUINCE THERAPEUTICS

Manager

Deal

£ 419 M

Total Value

dirk thye

CEO at QUINCE THERAPEUTICS

Manager

Deals

£ 492 M

Total Value

david lamond

Chairperson at QUINCE THERAPEUTICS

Manager

Deal

£ 419 M

Total Value

charles ryan

President at QUINCE THERAPEUTICS

Manager

Deal

£ 419 M

Total Value

pamela williamson

Head of Regulatory Affairs at QUINCE THERAPEUTICS

Manager

Deal

£ 419 M

Total Value

guenter r. janhofer

Chief Medical Officer at QUINCE THERAPEUTICS

Manager

Deal

£ 419 M

Total Value

giovanni mambrini

Chief Technology Officer at QUINCE THERAPEUTICS

Manager

Deal

£ 419 M

Total Value

thomas sabia

Chief Commercial Officer at QUINCE THERAPEUTICS

Manager

Deal

£ 419 M

Total Value

stacy roughan

Vice President, Corporate Communications & Investor Relations at QUINCE THERAPEUTICS

Manager

Deal

£ 419 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy